UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Outer Membrane Vesicles of a Human Commensal Mediate Immune Regulation and Disease Protection

Cell host & microbe, 2012-10, Vol.12 (4), p.509-520

2012

Link zum Volltext

Verfügbarkeit prüfen

DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies

Frontiers in immunology, 2023-11, Vol.14, p.1264882-1264882

2023

Link zum Volltext

Verfügbarkeit prüfen

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

PloS one, 2017-11, Vol.12 (11), p.e0188916-e0188916

2017

Link zum Volltext

Verfügbarkeit prüfen

281 Development of syngeneic mouse models to study the therapeutic efficacy of chimeric antigen receptor T cells against solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A322-A322

2023

Link zum Volltext

Verfügbarkeit prüfen

Getting MAD at MYC

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (40), p.9821-9823

2018

Link zum Volltext

Verfügbarkeit prüfen

Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells

The Journal of immunology (1950), 2013-12, Vol.191 (12), p.6231-6240

2013

Link zum Volltext

Verfügbarkeit prüfen

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

Journal of visualized experiments, 2019-03 (145)

2019

Link zum Volltext

Verfügbarkeit prüfen

The TBK1‐binding domain of optineurin promotes type I interferon responses

FEBS letters, 2016-05, Vol.590 (10), p.1498-1508

2016

Link zum Volltext

Verfügbarkeit prüfen

Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy

Cytotherapy (Oxford, England), 2022-07, Vol.24 (7), p.720-732

2022

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors

PloS one, 2010-06, Vol.5 (6), p.e11052-e11052

2010

Link zum Volltext

Verfügbarkeit prüfen

CD70 is downregulated by interaction with CD27

The Journal of immunology (1950), 2013-09, Vol.191 (5), p.2282-2289

2013

Link zum Volltext

Verfügbarkeit prüfen

Lack of the T cell–specific alternative p38 activation pathway reduces autoimmunity and inflammation

Blood, 2011-09, Vol.118 (12), p.3280-3289

2011

Link zum Volltext

Verfügbarkeit prüfen

c‐IAP ubiquitin protein ligase activity is required for 4‐1BB signaling and CD8+ memory T‐cell survival

European journal of immunology, 2015-09, Vol.45 (9), p.2672-2682

2015

Link zum Volltext

Verfügbarkeit prüfen

112 Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A69-A70

2020

Link zum Volltext

Verfügbarkeit prüfen

Balance between NF-κB p100 and p52 regulates T cell costimulation dependence

The Journal of immunology (1950), 2013-01, Vol.190 (2), p.549-555

2013

Link zum Volltext

Verfügbarkeit prüfen

Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70T293 and destabilization of the signalosome

Proceedings of the National Academy of Sciences - PNAS, 2018-02, Vol.115 (9), p.2174-2179

2018

Link zum Volltext

Verfügbarkeit prüfen

c-IAP1 and c-IAP2 redundancy differs between T and B cells

PloS one, 2013-06, Vol.8 (6), p.e66161-e66161

2013

Link zum Volltext

Verfügbarkeit prüfen

Rational design of TGFbRII dominant negative armored GPC3 CAR-T cells for the treatment of hepatocellular carcinoma

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.68-68.17

2023

Link zum Volltext

Verfügbarkeit prüfen

The CD8+ memory T-cell state of readiness is actively maintained and reversible

Blood, 2009-09, Vol.114 (10), p.2121-2130

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1695: Activation of B cells by CD73 blocking antibodies

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1695-1695

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2837: Synthetic TGFb blockade preserves effector function and maintains stemness of GPC3 CAR-T against hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2837-2837

2022

Link zum Volltext

Verfügbarkeit prüfen

109 Dominant-negative TGFβ receptor 2 enhances GPC3-targeting CAR-T cell efficacy against hepatocellular carcinoma

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A121-A121

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT097: First report of preliminary safety, efficacy, and pharmacokinetics of C-CAR031 (GPC3-specific TGFβRIIDN CAR-T) in patients with advanced HCC

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT097-CT097

2023

Link zum Volltext

Verfügbarkeit prüfen

Optineurin Insufficiency Impairs Interferon Regulatory Factor 3 (IRF3) but not NF-κB Activation in Immune Cells

The Journal of immunology (1950), 2013-11, Vol.191 (12)

2013

Link zum Volltext

Verfügbarkeit prüfen

Optineurin is dispensable for LPS- and Salmonella typhimurium -induced autophagy (INM3P.412)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.127-127.17

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outer Membrane Vesicles of a Human Commensal Mediate Immune Regulation and Disease Protection

DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

281 Development of syngeneic mouse models to study the therapeutic efficacy of chimeric antigen receptor T cells against solid tumors

Getting MAD at MYC

Optineurin insufficiency impairs IRF3 but not NF-κB activation in immune cells

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

The TBK1‐binding domain of optineurin promotes type I interferon responses

Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy

Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors

CD70 is downregulated by interaction with CD27

Lack of the T cell–specific alternative p38 activation pathway reduces autoimmunity and inflammation

c‐IAP ubiquitin protein ligase activity is required for 4‐1BB signaling and CD8+ memory T‐cell survival

112 Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy

Balance between NF-κB p100 and p52 regulates T cell costimulation dependence

Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70T293 and destabilization of the signalosome

c-IAP1 and c-IAP2 redundancy differs between T and B cells

Rational design of TGFbRII dominant negative armored GPC3 CAR-T cells for the treatment of hepatocellular carcinoma

The CD8+ memory T-cell state of readiness is actively maintained and reversible

Abstract 1695: Activation of B cells by CD73 blocking antibodies

Abstract 2837: Synthetic TGFb blockade preserves effector function and maintains stemness of GPC3 CAR-T against hepatocellular carcinoma

109 Dominant-negative TGFβ receptor 2 enhances GPC3-targeting CAR-T cell efficacy against hepatocellular carcinoma

Abstract CT097: First report of preliminary safety, efficacy, and pharmacokinetics of C-CAR031 (GPC3-specific TGFβRIIDN CAR-T) in patients with advanced HCC

Optineurin Insufficiency Impairs Interferon Regulatory Factor 3 (IRF3) but not NF-κB Activation in Immune Cells

Optineurin is dispensable for LPS- and Salmonella typhimurium -induced autophagy (INM3P.412)

Suchergebnisse filtern